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With the trend in miniaturization in scientific research, nanomaterial use in various 
disciplines has become widespread. Proteomic research is a distinct area beginning to 
utilize nanomaterials for different research methods. There are several issues inherent to 
nanomaterials use that must be overcome to ensure their widespread use is successful in 
proteomics based applications. Of these issues size control, surface chemistry control and 
applications efficiencies using nanomaterials are the most prominent issues hindering 
advancements. In current studies, nanoparticle synthesis utilizing polymer based 
encapsulation is a method that allows for a simple synthesis, size control, variety of surface 
chemistry, and still affords ionization efficiencies and enhancements on par with other 
nanoparticle syntheses. Therefore, polymer based encapsulation techniques are used 
throughout this study of nanomaterial based proteomic applications.  
Application efficiencies for nanomaterials in proteomic methods is a two-fold 
process: analytical methods and proteomic methods. Initially in this study, ionization 
efficiencies are investigated in mass spectrometry based analytical methods when using 
polymer encapsulated nanoparticles. This study was performed to ensure there is no 
significant degradation in efficiency when introducing the encapsulating polymers onto 
the surface of the nanoparticle during synthesis. Results showed that polymer introduction 
onto the surface of the nanoparticles did not interfere or significantly degrade the 
efficiencies with the mass spectrometry based analysis of standard peptide based samples. 
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Based on these findings polymer encapsulated nanoparticles were exploited for 
experiments to enhance proteomic based research methods.  
The polymer-encapsulated nanoparticles are also successfully utilized in 
applications for specific proteomic based methods that require a robust yet sensitive 
platform needed in the harsh environments common in proteomic based research. 
Specifically, these nanoparticles were shown to function as a selective capture platforms 
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Development of Mass Spectrometry Ionization 
There have been many ionization techniques developed for mass spectrometry 
since J.J. Thomson first refined the technique.  Some of these ionization techniques are 
very simple and others are more intricate; listed are a few examples of ionization 
techniques: electron impact1, chemical ionization2, fast atom bombardment (FAB)3, 
electrospray ionization (ESI)4, and matrix assisted laser desorption ionization (MALDI)5. 
The 2002 Nobel Prize in chemistry was awarded in part to John Fenn for the development 
of ESI-MS and Koichi Tanaka for the implementation of MALDI-MS for protein and large 
polymers4,6.  Both of these techniques are commonly utilized ionization techniques today 
for biological and large polymeric molecules7,8.  These two techniques are described as 
soft ionization techniques and their development has pushed mass spectrometry to the 
forefront of biological research as a tool for characterizing biological molecules 
specifically their primary, secondary, and tertiary structure.   
 
Nanoparticles in Mass Spectrometry 
Since Tanaka and coworkers showed in 1988 that proteins could be ionized using 
fine metal powders consisting of 30 nm cobalt nanoparticles, there has been interest in 
using other nanoparticles for LDI-MS6. Nanoparticles that have been studied for various 
uses include: Fe3O4
9, 10, TiO2
11, Ag12, Au13,14 , and SiO2
15.  This technique is often times 
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referred to as surface assisted laser desorption ionization (SALDI), but for this report it 
will be referred to as laser desorption ionization (LDI).  Nanoparticles offer several 
benefits when being utilized as platforms for LDI-MS: i) high surface area, ii) low 
interference in the mass-to-charge region of interest, and iii) ability to change the 
nanoparticle surface chemistry.  The most notable impact that nanoparticles have in mass 
spectrometry applications is the high surface area, which allows more analyte molecules 
to directly interact with the surface of the nanoparticles.  These nanoparticle surface 
analyte interactions should allow more analyte molecules to be ejected off the surface 
during the energy deposition/analyte ejection process.  Nanoparticles (NPs) have also been 
used to analyze a wide variety of samples such as small molecules and biological 
molecules (i.e. proteins and peptides) because of the NPs low interference in the low 
molecular weight region14.  The ability to control the surface chemistry of the NPs also 
permits cleaner ionization of target molecules16, 17.   
Modification of nanoparticles has been shown for several different types of 
nanoparticles such as AuNPs16 and Fe3O4
10.  In recent years, AuNPs have received a lot 
of attention for their use in LDI-MS because of a simple synthesis (citrate reduction18 and 
the method described by Brust et al.19), ease of altering the surface chemistry using ligands 
through thiol chemistry16, and their ability to absorb laser energy at differing wavelengths 
based on size and shape20.  Specifically, AuNPs that are modified using thiol chemistry to 
attach 4-aminothiol phenol (4-ATP) allowing the AuNPs to provide more protons for the 
ionization process which increased the mass range the AuNPs were capable of analyzing21.  
For example, Castellana and coworkers demonstrated similar chemistry applied to gold 
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nanorods (AuNR)20.  Using 4-ATP modified AuNRs for LDI-MS demonstrates the ability 
to utilize different wavelengths of lasers to ionize analyte from the surface.  Changing the 
shape of AuNPs to rods produces an absorption band, known as a surface plasmon 
resonance band22,23, at different wavelengths than that of spherical AuNPs allowing for 
the use of different photon wavelengths to produce analyte signal during the LDI-MS 
experiment. 
 
Proteomics and Mass Spectrometry 
 The study of proteins and their primary and modifications as well as their 
interaction with their surrounding is known as proteomics24.  The task of isolating and 
characterizing all proteins is a considerable task to undertake given the number of proteins 
in a proteome, the range in the concentrations of the proteins and the possible isoforms 
that may be present.  The advancements in mass spectrometry ionization techniques 
described by Karas and Hillencamp5, Tanaka6, and Fenn4 have helped pushed mass 
spectrometry to the forefront of proteomic research.  The soft ionization techniques 
combined with new developments in mass selections techniques have greatly increased 
the range, sensitivity, and resolution of mass spectrometers allowing them to be a valuable 
tool in proteomic studies.  Many proteomic studies are conducted in following one of two 
experimental procedures: i) bottom-up and ii) top-down.  Bottom-up utilizes an enzyme 
that will cleave proteins at certain residues producing peptides that are then analyzed using 
MS7,25.  Bottom-up proteomics have challenges associated with analyzing samples that 
contain post translational modifications (PTM) such as ion suppression and loss of PTM.  
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Because of these challenges, techniques for enrichment of PTMs have been developed for 
several of the most commonly studied PTMs including phospho- and sulfo-peptides26,27, 
28. However, bottom-up proteomics have databases that allows for researchers to more
easily identify proteins in the sample7.  Another common proteomic strategy is top-down 
proteomics29.  Top-down proteomics involves the analysis of intact proteins to determine 
the protein mass to charge ratio (m/z) followed by a fragmentation method that is carried 
out within the mass spectrometer to gain amino acid sequence information for the protein 
of interest29.  This method allows for retention of post translational modifications and the 
possibility of greater sequence coverage due to the fragmentation occurring in the gas 
phase within the mass spectrometer.  Top-down proteomics also has challenges present 
such as no readily available database for easy protein identification and the need for large 
quantities of isolated pure protein to allow for optimal results.  Both of these methods have 
their benefits as well as short comings for use in proteomics.  There have been several 
techniques developed to overcome some of these short comings especially for bottom-up 
approaches since this method allows for facile database searches for protein identification. 
 Translational Modification Enrichment 
As with any field of research, there are limitations in proteomic studies; one such 
limitation is the handling and detection of post-translational modifications (PTM).  Post-
translational modifications are additions or deletions typically to specific residues within 
protein sequence that affect the properties of proteins typically through structural changes 
or function of the protein within the cell.  These modifications have a dynamic range of 
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concentrations within the proteome and there are many types of modifications that are 
reversible and irreversible.  Therefore, techniques are needed that are able to handle PTM 
in a bottom-up proteomics experiment.  There have been several methods developed over 
the past few decades for selectively capturing some of these PTMs such as lectin affinity 
columns for glycosylation30 and immobilized metal affinity chromatography (IMAC) for 
phosphorylation31, 32.  These techniques along with many others used for PTM selective 
capture are chromatographic in nature requiring making and loading columns with the 
various chemical or metal ions.   However, recently there have been many advances in 
these techniques that no longer involve columns. 
Phosphorylation Tagging and Enrichment Techniques 
Phosphorylation is one of the most common post translational modifications found 
throughout biology.  Phosphorylation plays an important role in determining protein 
activity through phosphorylation and dephosphorylation of receptor sites that causes 
conformational changes in the site resulting in the “on” and “off” switching of the protein 
activity.  An estimated ~40% of all proteins in eukaryotic cells are phosphorylated at any 
specific time, and of the ~40% of proteins that are phosphorylated there are an estimated 
100,000 possible sites for modification in the mammalian proteome33.  As mentioned 
above, the detection of PTMs such as phosphorylation is a difficult task due to the number 
of possible modification sites and dynamic range in concentration with the modification 
from protein to protein.  Several enrichment techniques have been developed for more 
efficient detection of phospho-modified peptides and proteins.  Of these enrichment 
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techniques, several of them require labeling of the modification with tags that allow for 
enrichment of the peptides/proteins.  First, labeling-based enrichment techniques 
including β elimination/Michael addition34 and phosphoramidate chemistry35 are a few of 
the more well studied of these techniques.  Among these labeling techniques, the β 
elimination/Michael addition is the most commonly employed; this technique is only 
applicable for phosphoserine (pSer) and phosphothreonine (pThr)34.  The technique 
involves the elimination of the phosphate group from the amino acid side chain, using 
highly basic conditions producing the dehydroalanine derivative from pSer and β-
methyldehydroalanine derivative from pThr.  These derivatives then serve as a Michael 
acceptor, allowing for the attachment of a nucleophile for enrichment.  A technique that 
has become more popular in recent years is phosphoramidate chemistry (PAC) based 
enrichment which was developed based on derivatization schemes for nucleotides36.  PAC 
based enrichment is applicable to all commonly modified amino acids phosphoserine, 
phosphothreonine, and phosphotyrosine, while PAC allows for enrichment of all known 
phospho- modified amino acids.  PAC method requires several preliminary steps before 
enrichment can be carried out.  Specifically, all amines and carboxyl groups require 
modification to block as many false positive tagging events as possible, prior to tagging 
the phosphate groups.  Following the derivatization of the phosphate groups, there are 
several enrichment methods that can be used including IMAC37  and more recently the 
derivatization step is carried out using amine terminated polyaminoamide dendrimers 
(PAMAM)36.  Using dendrimers allows enrichment based on size exclusion techniques. 
These two specific examples, along with other chemical based tagging methods are ways 
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to create derivatives that are specific for pSer, pThr, and pTyr, which allow for the 
enrichment of the phospho- modified peptide/ protein. 
The enrichment of phosphopeptides/proteins through affinity methods such as 
IMAC38, titanium dioxide MOAC39, and strong cation exchange (SCX)40 without 
derivatization of the peptides/proteins prior to enrichment has also been described.  
Immobilized metal affinity chromatography (IMAC) is the most commonly used 
technique for the enrichment of phosphopeptides/proteins in an offline based column 
format in modern proteomic research.  With IMAC positively charged metal ions, such as 
Fe3+ 31 or Ga3+ 41, are coordinated to the surface of a solid phase resin through metal ion 
chelators, typically nitilotriacetic or iminodiacetic acid.  Following the coordination of 
metal ions, the now positively charged resin is subjected to the negatively charged 
phosphoryl groups that captures the metal ions through electrostatic interactions.  MOAC 
is an enrichment method for phosphopeptides/proteins that is similar to IMAC, but in place 
of metal ions being loaded into the surface of resin beads are metal oxides such as TiO2
11.  
Another method for enrichment that is specifically used phosphopeptides is strong cation 
exchange (SCX)42.  This enrichment method also utilizes the interaction of a positively 
charged column with the negatively charged phosphate groups.  To achieve separation of 
peptides from the column, phosphopeptides and nonphosphopeptides, the elution of 
peptides off the surface is done by changing the isoelectric point (pI).  These methods are 
examples of many that have been described for the selective enrichment of 
phosphopeptides/proteins through affinity interactions.  These techniques being both 
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online and offline chromatographic techniques, lend themselves to use for proteomic 
studies where mass spectrometry is used as a detection method. 
Oxidized Cysteine Enrichment 
Cysteine is a very important amino acid in the function of proteins due to it reactive 
thiol side chain, –SH.  The thiol functionality allows for the oxidation and reduction of 
proteins to help control the activity in transduction pathways within cells43-45.  The 
formation of sulfenic acid (R-SOH) and sulfinic acid (R-SO2H) are oxidation products 
found in cells that are reversible, and they allow cells to process hydrogen peroxide or 
alky hydroperoxides to non-reactive species that will not damage the cells46.  While these 
two products are reversible, there is a third product of oxidation to cysteine, sulfonic acid 
(R-SO3H).  Sulfonic acid modified cysteines have undergone several steps of oxidation to 
produce an irreversible oxidized stated of cysteine47. While the reversible oxidation states 
of cysteine are important, they are very difficult to trap due to their reversibility.  However, 
the irreversibly modified sulfonic acid cysteines (cysteic acid) provide a simpler target for 
detection of oxidation sites within proteins.  Methods have been developed for the capture 
of cysteic acid that included the use of antibodies48 and modified nanodiamonds28. The 
technique developed using nanodiamonds is based on electrostatic interaction of positively 
charged nanodiamonds.  Briefly, the surfaces of nanodiamonds are modified with 
polyarginine using several steps of EDC/NHS coupling28. Following the surface 
modification, peptide mixtures and protein digests containing cysteic acid modification 
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are captured on the surface through electrostatic interactions and then subjected mass 
analysis through MALDI-MS28. 
Nanoparticles in Post Translational Modification Enrichment 
Recently, nanoparticles of various types have been studied for use in PTM 
enrichment as an alternative to traditional chromatographic techniques used for these 
enrichments. Nanoparticles used in the enrichment of PTMs vary from Fe3O4 to gold 
nanoparticles (AuNPs).  The simplest nanoparticle enrichment scheme is using the 
nanoparticles as synthesized without any modifications to enrich post translational 
modifications.  This enrichment scheme has been done using TiO2 for direct 
phosphopeptide enrichment49 and using AuNPs for the enrichment of thiol containing 
compounds, such as cysteine containing peptides through direct interaction with the 
nanoparticle surface50.  While these methods are the simplest and a common use of 
nanoparticles in the enrichment of PTMs, altering the surface chemistry of the 
nanoparticles to allow for efficient enrichment of specific PTMs can also be used.  These 
modifications can include various non-covalent binding motifs for PTMs such as 
antibodies or metal binding ligand48. Antibodies have been coupled to magnetic 
nanoparticles for their use in a human plasma immunoassay51. Magnetic nanoparticles 
have also had metal chelating ligands, such as those used in traditional IMAC, attached 
for the selective enrichment of both His-tagged proteins and phosphorylated peptides52. 
Other nonmagnetic nanoparticles have also been modified for non-covalent enrichment, 
including AuNPs.  Specifically, gold nanorods (AuNR) have been modified with lipid 
layers to capture myristoyl modified peptides and other membrane active molecules13. 
Polymers Used for AuNP Synthesis 
Recently, synthesis of metal nanoparticles with polymers has been gaining 
significant interest.  Polymers such as: PAMAM dendrimers53, PMMA,54, PNIPAM55, 
PVP56, and various block copolymers57 have been used in these systems as they offer a 
surface that is biologically compatible and stabilizes the NPs for long periods of time, 
these characteristics are crucial for NPs use in biological studies.  The polymer/NP 
systems have been studied in applications for: drug delivery58, surface enhanced Raman 
studies (SERS)59, and use in thin film development using NPs60,61,57.  One polymer that 
has been used of particular interest for this report is poly(4-vinylpyridine) P4VP  This 
polymer allows synthesis of polymer encapsulated AuNPs with a narrow size distribution 
that are stable in solution for long periods of time61. Pyridine groups on the back bone of 
the polymer interact with the surface of the AuNP encapsulating these AuNPs in the 
polymer following reduction of HAuCl4 in solution (Scheme 1).  There are free pyridine 
pendant groups that are not bound to the surface, and these pyridines have been shown to 
hydrogen bond to acidic polymers, lending to a method for layer formation with AuNPs 
embedded in the layers61.  Along with P4VP, another polymer system that has been used 
for NP synthesis is PAMAM dendrimers62.  Dendrimers allow for a simple one pot 
synthesis that has the advantage of controlling the size of the NPs while also providing a 
platform that is stable and ridged.  The dendrimers allow for controlling the surface 
10 
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chemistry through post NP synthesis functionalization by simple chemical coupling 
reactions with the terminal groups on the dendrimer arms that can provide essential 
function for the dendrimer NP complexes such as use in posttranslational modified peptide 
capture63,64.    
Scheme 1. Synthetic scheme for poly(4-vinylpyridiene)(P4VP) encapsulates AuNPs. 
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CHAPTER II 
POLYMER ENCAPSULATED GOLD NANOPARTICLES USED FOR LDI-MS: AN 
INVESTIGATION OF THE EFFECTS OF PEPTIDE INTERACTIONS WITH THE 
SURFACE ON IONIZATION EFFICIENCY 
Introduction 
The interest in utilizing nanoparticles as a matrix for LDI-MS began with Tanaka 
and coworkers, who showed that biological molecules and large polymers can be ionized 
using fine powders consisting of 30 nm cobalt nanoparticles6.  Subsequently, a variety of 
nanoparticles12,14,16,65-71 have been investigated as potential matrices for LDI-MS, and 
have allowed for the study of a wide variety of analytes in LDI-MS. For example, small 
molecules using SiO2 NPs
15, biological molecules (proteins and peptides) using AuNPs68, 
and AgNPs have been used to selectively ionize molecules such as the analysis of olefins 
and cholesterol 12.  In recent years, AuNPs have received increased attention for their use 
in LDI-MS owing to the ease of AuNPs synthesis which allows for great control of size, 
particle shape, and the ability to alter the surface chemistry of the nanoparticles after 
synthesis with simple ligand exchange 72.  AuNPs can be synthesized to create an array of 
shapes which can lead to distinct optical properties further exploiting their capabilities for 
LDI-MS by allowing for various laser wavelengths to be used.   
Although the ability to synthesize AuNPs with controllable optical properties is 
relatively straightforward, there are difficulties associated with using AuNPs for use in 
mass spectrometry (MS) analysis. Our lab has previously shown that salts and other 
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contaminates present in the samples, either from the analytes or AuNPs, greatly affect the 
LDI ion yields for analytes in both the positive and negative ion mode67.  The primary 
concern is that the synthesis of AuNPs is “dirty”, resulting in several species present that 
are not conducive to MS analysis owing to interactions with the AuNP or the analytes.  
The standard synthesis of AuNPs relies on using sodium citrate as a protecting agent for 
the AuNPs; the electrostatic interaction between the citrate and the AuNPs prevents the 
particles from aggregating to form larger particles.  The adverse effects citrate has on ion 
yields in mass spectrometry can be overcome by displacing citrate from the AuNPs with 
protecting agents such as 4-aminothiolphenol (4-ATP) 68, either during synthesis or 
subsequently by ligand exchange.  The physical interaction the protecting agents have with 
the AuNPs is important to consider when using AuNPs to desorb/ionize analytes from the 
surface.  Changing the surface properties of AuNPs by altering the ligands used to stabilize 
the NPs can lead to cleaner spectra as well as enhance the ionization of biological 
molecules.  Altering the surface chemistry by using a molecule such as 4-ATP provides 
enhanced ionization efficiency for peptides and allows for ionization of proteins 68.  Our 
lab has recently illustrated that changing the shape of the AuNP can facilitate ionization 
of biologically relevant molecules using different wavelength lasers20.  Furthermore, it has 
been demonstrated that alternate shapes of gold nanomaterials can be used to enrich 
specific analytes from complex mixture13.  The physical interaction between protecting 
agents and analytes as well as the chemical properties of the protecting agent are important 
to consider when using AuNPs for LDI-MS.   
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Based on previous results, the use of alternative protecting agents could hold utility 
for synthesis of AuNPs and for use in LDI-MS. The use of various polymers as protecting 
agents on the surface AuNPs has been studied extensively because of their ability to 
stabilize the NPs through multiple interactions between the surface of the nanoparticles 
and the polymers.  Polymer protecting agents are attractive for use as protecting agents 
because the passivation of the AuNPs with polymers affords improved stability of the 
particles for long periods of time through various types of interactions with the surface.  
Several polymers have been used to encapsulate nanoparticles including poly(N-
isopropylacrylamide) (PNIPAM)55, poly(4-vinylpyridine) (P4VP)17,61, poly(methyl 
methacrylate) (PMMA)54, poly(vinylpyrrolidone) (PVP)56, and DNA73.  Block co-
polymers have also been used as protecting agents for AuNPs such as 
poly(ethyleneoxide)-polystyrene (PEO-PS)60 and polystyrene-b-poly(-vinylpyridine) (PS-
b-PVP)74,75.  Using polymers as protecting agents for AuNPs allows for the tailoring of 
the surface of the NPs to be altered in a manner that the AuNP polymer complex becomes 
useful in biological systems.  Examples of this are pH responsive polymers allowing the 
AuNPs to aggregates76, and  polymers that can be used  to deliver molecules through 
temperature induced changes in the polymers themselves77.  Polymers that have the ability 
to interact with analytes in a similar fashion to other organic molecules could provide an 
enhancement in ionization of peptides from LDI-MS utilizing encapsulated AuNPs and 
could serve as a viable matrix in mass spectrometry.  
In this study, we aim to gain a better understanding of how the surface of 
nanoparticles functionalized with poly (4-vinylpyridine) interacts with peptides and how 
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these interactions, or lack thereof, will effect ionization efficiencies of the peptides in LDI-
MS.  To accomplish this we use P4VP to synthesize polymer encapsulated AuNPs 
(P4VP/AuNPs) with a narrow size distribution that are stable in solution for several weeks.  
Pyridine groups on the backbone of the polymer interact with the surface of the AuNP 
encapsulating these particles following reduction of HAuCl4 in solution.  Some of the 
pyridine units will have no direct interaction with the AuNP surface, and they can interact 
with other molecules suspended in the solution.  We demonstrate that using a polymer as 
a protecting agent on AuNPs is straightforward and provides a simple method to 
circumvent the contamination problems associated with commercially available citrate 
capped AuNPs when considering their use in LDI-MS.  Finally, we show that 
P4VP/AuNPs lead to enhanced ionization efficiencies for peptides when compared to 
citrate capped AuNPs similar to those previously studied68. 
Experimental 
Materials 
Hydrogen tetrachloroaurate (III) (HAuCl4), poly(4-vinylpyridine) (P4VP), 
trifluoroacetic acid (TFA), methanol (MeOH), ammonium acetate, formic acid (FA), and 
trifluoroethanol (TFE) were purchased from Sigma Aldrich (St. Louis, MO).  Sodium 
borohydride (NaBH4) was purchased from EMD Chemicals Inc. (Darmstadt, Germany).  
Citrate capped gold nanoparticles, and 400 mesh carbon coated copper grids were obtained 
from Ted Pella Inc. (Redding, CA). The peptides [Val4] angiotensin III (RVYVHPF), 
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human ACTH clip 6-24 (HPRWGKPVFKKRRPVKVYP), C-telopeptide (ELAHDGGR), 
angiotensin II (DRVYIHPF), and neurotensin (Glp-LYENKPRRPYIL) were purchased 
from American Peptide Company Inc. (Sunnyvale, CA).  Molecular weight cutoff filters 
(MWCO) 100 kDa and 10 kDa, as well as Milli-Q water were obtained from Millipore 
Corp. (Bedford, MA).   All reagents and peptides were used as received without further 
purification. 
AuNP Preparation 
AuNP’s were synthesized using the method previously published by Hao et al61. 
The reaction scheme is depicted in Scheme 2.  After the P4VP/AuNPs were synthesized, 
the sample was lyophylized to dryness to remove the solvent and the remaining solid 
pellets were washed twice using 500 µL of 18 MΩ water, then resuspended in 0.1% TFA 
followed by sonication.  The resulting solution was further purified using MWCO filters 
of 100 kDa, and the solution volume was reduced to one tenth the initial volume in 0.1% 
TFA at the end of purification. 
 Characterization  
P4VP/AuNPs were characterized using two different methods: (i) UV-Vis 
spectroscopy and (ii) transmission electron microscopy (TEM).  For the UV-Vis 
characterization an Agilent 8453 UV-Vis spectrometer (Agilent Technologies, Santa 
Clara, CA) was used.  The UV-Vis spectrum was acquired from 200nm to 900nm using a 
1:3 (P4VP/AuNP:MeOH) dilution in a 1 cm quartz cuvette. TEM was carried out by 
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spotting 1 µL of the AuNP synthesis solution on a 400 mesh carbon coated copper grids 
with a JOEL JEM 2010 (Peabody, MA) microscope at 200 kV.  The X-ray photoelectron 
spectroscopy (XPS) was performed on a Kratos Axis Ultra Imaging X-ray photoelectron 
spectrometer using mono Al source (Kratos Analytical, Manchester, United Kingdom). 
Scheme 2. Reaction scheme for the production of P4VP encapsulated AuNPs. The 
right hand side of the scheme depicts the AuNP coated in polymer with pyridine 
subunits not interacting with the surface of the NP, leading to free pyridine subunits. 
Preparation and Laser Desorption/Ionization (LDI)  
Serial dilution of peptide stock solutions (1mg/1mL) was used to obtain a range of 
analyte concentrations for this study.  Peptides were mixed directly with either the 
commercially available citrate capped AuNPs or P4VP/AuNPs, at the ratio:  1 µL of 
peptide was mixed with 9 µL of AuNP solution.  Final concentrations of the peptides used 
in this study after mixing with the AuNP solutions were 100 M, 75 M, 50 M, 25 M, 
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10 M, 7.5 M, 5 M, 2.5 M, and 1 M. One microliter of the resulting mixture was 
then spotted onto a stainless steel MALDI plate and the spots were dried using a speed 
vacuum. All samples were analyzed using a Voyager - DE STR (Applied Biosystems, 
Framingham, MA) in the positive ion reflected mode using a 337 nm laser with an 
acceleration voltage of 20 kV, grid voltage of 67%, delay time of 200 nsec, and ~9 J per 
laser shot.  
Results and Discussion 
In this work we incorporate a polymer-based method to synthesize AuNPs, in 
which the particle size is controlled and can be used to facilitate LDI-MS.  The synthesis 
of the poly(4-vinylpyridine) (P4VP) encapsulated AuNPs (P4VP/AuNPs).  This provided 
a wine red solution typical of a gold colloidal solution consisting of particles larger than 
2 nm in diameter.  To characterize the resulting, P4VP/AuNPs, UV-Vis spectroscopy, 
transmission electron microscopy (TEM), and x-ray photoelectron spectroscopy (XPS) 
were used.  The UV-Vis spectrum (Figure 1a) exhibits two absorbance maximums; (i) 
The peak at 250 nm corresponds to the polymer specific to the pyridine groups, and (ii) 
the 520 nm absorbance is characteristic of AuNPs, larger than 2 nm in diameter, consistent 
with the color of the AuNP solution.  To confirm the size of the AuNPs, TEM images 
were obtained (Figure 1b) and the average size distribution was determined to be 2.4 ± 
0.6 nm. The size is important to consider when using P4VP/AuNPs for LDI-MS, as it has 
been shown that 5 nm AuNPs yields higher relative abundances of peptide ions compared 
to the use of  smaller (< 2 nm) and larger (> 10 nm) AuNPs.   
19 
Figure 1. a. Characteristic UV-Vis spectra for P4VP encapsulated AuNPs with an 
absorbance at 520 nm and 250 nm representing AuNPs and P4VP. b. TEM image 
at 100k magnification of P4VP AuNPs. Average size distribution is 2.4 + 0.6 nm. 
XPS analysis was run on the P4VP/AuNPs to better determine the surface chemistry of 
the AuNPs.  The high resolution scan of the nitrogen 1s electron binding energies displays 
two peaks at 399.8 eV and 402.4 eV, Figure 2a.  The two peaks correspond to the two 
different types of pyridyl nitrogens present in the sample.  The first of the nitrogen peaks 
is due to interaction with the surface of the AuNPs.   The second nitrogen peak is due to 
the lack of surface interaction; therefore, has a binding energy.  High resolution scans of 
gold 4f electrons were also performed on the same sample and displays two peaks that 
correspond with known gold 4f electron binding energies, Figure 2b.  
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Figure 2. a. High resolution nitrogen 1s electron x-ray photoelectron spectrum 
taken from P4VP/AuNPs. b. High resolution gold 4f electron x-ray photoelectron 
spectrum taken from P4VP/AuNPs. 
Following the characterization of the AuNPs, we conducted experiments with 
peptides using P4VP/AuNPs in LDI-MS to determine the viability of these P4VP/AuNPs.  
A number of peptides were examined including human ACTH clip 18-39 
(RPVKVYPNGAEDESAEAFPLEF) and [Val4] Angiotensin III (RVYVHPF), in which 
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representative spectra for both peptides are provided in Figure 3a and 3b respectively. 
LDI-MS of each peptide was also performed in the absence of P4VP/AuNPs, in which no 
analyte signal was observed at the same laser energies and peptide concentration used to 
analyze the peptide P4VP/AuNP mixture. Additionally we compared the peptide 
ionization efficiencies of P4VP/AuNPs to citrate capped AuNPs. Higher laser fluence was 
required when using the citrate capped AuNPs to achieve desorption/ionization of the 
peptides examined.  Moreover, the most abundant ion signal in the spectra for the peptides 
analyzed with the citrate capped AuNPs was the [M+Na]+ ion whereas analysis using 
P4VP/AuNPs resulted in the [M+H]+ ion being the predominate ion signal observed.  The 
high abundance of the [M+Na]+ and [M+K]+ ions when using the commercially available 
AuNPs can be explained by the presence of alkali metals which act as counter ions to the 
citrate group, which is used as the capping agent during the synthesis.  The presence of 
alkali metals in the citrate capped AuNPs has been shown to be a possible drawback to 
MS analysis because of the formation of alkali adducts.  Conversely, there is little alkali 
metal present in the synthesis of P4VP/AuNPs, and through a centrifugation cleanup 
procedure performed before using in LDI-MS experiments, a majority of the residual 
alkali metals are removed.  The final step in the cleanup process utilizes diluting the 
P4VP/AuNPs in an acid solution.   
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Figure 3. a. LDI-MS spectrum of Val4Angiotension III, RVYVHPF m/z 916.5, with 
P4VP encapsulated AuNPs. The [M+H}+ and [M+Na]+ are observed as predominate 
peaks in the spectrum. b. LDI-MS spectrum of human ACTH (18-39), 
RPVKVYPNGAIDESAEAFPLEF m/z 2465.2, with P4VP encapsulated AuNPs. 
Observed peaks in the spectra that are characteristic of the polymer NP complex (*), 
the [M+H]+ and [M+Na]+ are observed for the analyte. 
It is also important to note that through the synthesis there will be pyridine subunits that 
do not interact with the surface of the AuNP, see Scheme 1.  The addition of acid leads to 
protonation of the free pyridines, which helps solubilize the P4VP/AuNPs and provides a 
source of protons during the laser desorption experiment.   Low abundance signals of the 
alkali metal adducted peptides could result from alkali contaminates in the peptide 
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solutions.  It should also be noted there are no interference peaks from the polymer in the 
mass range observed in the spectra seen in Figure 3b. 
 Once it was determined P4VP/AuNPs were capable of generating protonated 
signal for peptides a range of peptides were studied.  These peptides had differing amino 
acid sequences and varying isoelectric points (pI); results of these studies can be seen in 
Figure 4.  When studying the various peptides patterns are observed for angiotensin II 
and human ACTH clip (6-24) which show an increase in ion counts for these peptides as 
the amount spotted decreases to 75 picomoles, Figure 4a and Figure 4d.  Following this 
increase there is a decrease in ion counts until there is no signal detected for these peptides.  
One possible rationalization for this observation is that the size and ring structure of the 
side chains (i.e. phenylalanine, histidine, tyrosine, proline, and tryptophan), which effects 
folding of the peptide, could directly interact with the P4VP/AuNPs.  This interaction 
could alter the distance between the AuNP resulting in changes to desorption and 
ionization process for the peptides.   Since the AuNPs are absorbing the photons and 
transferring their energy to the peptides for desorption, this interaction is extremely 
important to consider.  If this interaction causes the peptides to exist at a distance in which 
the peptide will no longer feel the effects of the AuNPs desorption process, then the 
peptides will presumably not be desorbed off the surface.  Alternatively if multiple side 
chains of the peptide interact with the polymer or surface of the AuNPs, the interaction 
could be strong enough that the peptide may not be desorbed off the surface.  Interactions 
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between proteins, peptides and nanoparticles have been previously described wherein the 
binding energy and structure of the protein or peptide changes due to the interactions78-81.  
Figure 4. Graphs that present the concentration of peptide vs. average ion counts for 
[M+H]+. The peptides are a. angiotensin II (DRVYIHPF) m/z 1046.5, pI 6.74, b. 
Val4Angiotensin III (RVYVHPF) m/z 917.1, pI 8.75, c. C-telopeptide (EKAHDGGR) 
m/z 868.9, pI 6.85, and d. human ACTH clip (6-24) 
(HFRWGKPVGKKRRPVKVYP) m/z 2335.9, pI 11.75. All error bars are in the 
form of percent error.  
Two interactions that could be affecting the ionization efficiency of angiotensin II 
(Figure 4a) and human ACTH clip 6-24 (Figure 4d) could be electrostatic or hydrophobic 
stacking with the polymer on the surface of the P4VP/AuNPs.  To test this theory, we 
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compared angiotensin II which contains four amino acids considered to be large 
hydrophobic side chains (Tyr, His, Phe, etc…), to C-telopeptide which has one such amino 
acid (His).  We predict that C-telopeptide should have higher ionization efficiency, which 
data in Figure 4c confirms.  As the amount of peptide deposited with the nanoparticles 
decreases, the angiotensin II signal begins to show an increase in the ionization efficiency 
before it too begins to decrease.  This trend could is suggestive that hydrophobic 
interaction through pi stacking with the polymer has a significant effect on the ionization 
efficiency.  One conclusion is as the concentration of peptide within the spot increases, 
layers of peptide buildup on to the surface of the P4VP/AuNPs due to the hydrophobic 
interactions until the loading of the peptide reaches a maximum capacity.  Once this 
capacity has been exceeded not all of the peptide can be desorbed/ionized off the surface 
of the AuNPs, causing the lowered ionization efficiency at higher concentrations.  Another 
conclusion is that electrostatic interactions could be very strong through several side chain 
polymer interactions causing the peptides to not be desorbed off the surface of the AuNPs.  
This seems unlikely, as the peptides seem to recover ionization efficiency once the 
concentration has been lowered and the pH of the solution suggests that all peptide and 
polymer charge sites will be protonated, lowering interaction potential.  We wanted to 
investigate whether or not these peptide interactions with the AuNPs were actually causing 
the signal reduction at higher peptide concentrations.  In order to accomplish this, we 
altered the solvent conditions, with the hopes that changing the solvent would change the 
interactions the peptides might have with the P4VP/AuNPs, in which the peptides were 
dissolved before mixing with the AuNPs.  
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The study of the effect of solvent was carried out using a peptide that contains 
several amino acids with side chains that are large and can interact with the polymer layer 
on the AuNPs as well as side chains that can be easily protonated, human ACTH clip 6-
24. This peptide also follows the trend of increasing ionization efficiency as the
concentration decreased until a certain point where the ionization efficiency begins to 
decrease (Figure 4d).  To better understand which of these interactions could possibly 
cause this ionization efficiency trend we chose to use a buffer solution (ammonium 
acetate) and two different organic solvents (trifluoroethanol and methanol).  The 
ammonium acetate (AA) trend line in Figure 5 has the highest ionization efficiency for 
all of the solvents chosen.  This can be attributed to the availability of protons in the 
mixture as the ammonium acetate was buffered using formic acid.  The proton availability 
is important due to the binding energy of a hydrogen to a pyridyl nitrogen is ~900 kJ/mol 
therefore the ability of the peptide to strip a proton from these sites during the laser 
desorption and ionization process is low82. 
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Figure 5. A plot containing a comparison between concentration of human ACTH 
clip (6-24)(HFRWGKPVGKKRRPVKVYP) m/z 2335.9, pI 11.75, vs. average ion 
counts [M+H]+ in different solvent conditions. All error bars are in the form of 
percent error.  
Thus, in this buffer solution the human ACTH clip 6-24 is more readily protonated as the 
peptide is not competing with the pyridine groups for the protons leading to an expected 
trend in ionization wherein the average [M+H]+ counts decreases as the concentration 
decreases.  Alternatively, the proton availability with the P4VP/AuNPs also leads to the 
lower ionization efficiency of human ACTH clip 6-24 in the other solvents shown in 
Figure 5.  Trifluoroethanol (TFE) was investigated because of its ability to hydrogen bond 
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with the peptide and the pyridine group preventing any possible interactions between the 
peptide and the pyridine encapsulated AuNPs83. TFE can also preserve the secondary 
structure within proteins by reducing the hydrophobic interactions with other molecules 
of similar structure83,84,85.  The data for TFE in Figure 5 show that the ionization efficiency 
for the peptide is lower than that of the ammonium acetate and water but is similar to 
methanol. This lowered ionization efficiency could be a result of the peptide being 
protected by the TFE molecules that are hydrogen bonded both to the peptide as well as 
to the pyridyl nitrogens surrounding the AuNP.  Hence the peptide will not be able to 
interact closely enough with the P4VP/AuNPs to either gain a proton from the pyridine, 
or is not able to interact with the AuNP in a manner that allows the peptide receive the 
energy deposited by the laser during the LDI-MS experiments.  To further test the effects 
of the solvent we studied methanol because of its propensity to disrupt the hydrophobic 
interactions the peptide could have with the P4VP encapsulating the AuNPs without 
having as strong interactions as TFE.  Since these two organic solvents display similar 
trends in ionization efficiency with human ACTH clip 6-24 (Figure 5), we can conclude 
that their ability to reduce the effect of hydrophobic interactions the peptide has with the 
P4VP/AuNPs.  From these data we can determine that the major causes of the observed 
trends are twofold a) the availability of protons in the solution of the peptide and b) the 
hydrophobic interaction the peptide has with the P4VP/AuNPs. 
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Conclusion 
With the focus of modern research trending toward biochemical issues, it is 
important to understand how molecules interact with surfaces, such as those of AuNPs 
and their protecting agents; this includes optimizing methods to analyze these 
molecules/systems.  The use of poly(4-vinylpyridine) (P4VP) to synthesize AuNPs yields 
not only a small size distribution of AuNPs but incorporates a proton source into the 
system.  Using P4VP/AuNPs for LDI-MS provides a similar platform to citrate capped 
AuNPs with few interference peaks observed in the mass spectrum.  However, the polymer 
bound to the surface of the AuNPs reduces the presence of alkali metal adducts seen in the 
mass spectrum making P4VP/AuNPs a viable platform for peptide analysis through LDI-
MS.  Although, using P4VP/AuNPs have benefits over citrated capped AuNPs there are 
several things to consider about P4VP/AuNPs as an LDI-MS platform such as the 
interaction, hydrophobic and electrostatic, an analyte could have with polymer subunits 
and these interactions effect on ionization efficiency for the analyte.  From this study we 
have demonstrated that the use of organic solvents to dissolve the peptide human ACTH 
clip 6-24 can disrupt the hydrophobic interactions between the amino acid side chains and 
the polymer subunits.  This causes the ionization efficiencies to be lowered as a result of 
the decreased interaction with the AuNPs.  Also involved in the lowering of the ionization 
efficiencies is the low availability of protons in the P4VP/AuNPs which could be an effect 
of the proton affinity of pyridine, which can be overcome by the solvent being used having 
excess protons incorporated within them.   Therefore, we can conclude that solvent effects 
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on peptides interactions are important and proton availability is also very important to 
consider when using P4VP/AuNPs for LDI-MS of peptides.   
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CHAPTER III 
POLY(4-VINYLPYRIDINE) ENCAPSULATED GOLD NANOPARTICLES AS AN 
ENRICHMENT METHOD FOR PHOSPHORYLATED PEPTIDES AND PROTEINS 
Introduction 
There are significant challenges in proteomic research associated with 
posttranslational modifications (PTMs).  The dynamic range and complexity of the 
possible modifications has led to the development of methods that selectively capture 
specific functionalities of posttranslational modifications.  Immobilized metal ion 
chromatography (IMAC) and metal oxide affinity chromatography (MOAC) for 
phosphorylation86, lectin affinity chromatography for glycoproteins30, and covalent 
chromatography for cysteine containing peptides87 are examples of these functionality 
specific capture methods.  More recently, there have been enrichment methods for subsets 
of peptides through labeling using facile bioaffinity tags88.  These methods both coupled 
with mass spectrometry (MS) have overcome several of the challenges present in 
posttranslational modification proteomic research.   
There has been a substantial research movement toward using nanomaterials for a 
variety of applications, specifically surface chemistry with applications in mass 
spectrometry16,20,69,81,89-95.  The use of surface modified gold nanoparticles (AuNPs) for 
the ionization of biological molecules (proteins and peptides)95,96, as well as silver 
nanoparticles (AgNPs) have been used to selectively ionize molecules such as the analysis 
of olefins and cholesterol12.  With the advancement of nanomaterials in mass 
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spectrometry, the realm of possibilities of using functionalized nanomaterials for selective 
capture platforms has become a research interest in the field of proteomics16,53,16,52,97-101.  
One specific example wherein Lai et al.38 synthesized magnetic Fe3O4 nanoparticles that 
are then functionalized post synthesis with standard metal coordinating molecules (NTA) 
used in IMAC columns.   Following the synthesis and functionalization these magnetic 
nanoparticles are demonstrated capturing histidine tagged and phosphorylated 
peptides/proteins38.   The demonstration of these surface modified nanoparticles opens the 
possibility for nanoparticles that need no further modifications before they are useful as 
selective capture platforms.   
Nanoparticle synthesis is a large and highly researched field, and the synthesis of 
AuNPs is of particular interest to this research.  Brust et al.102 described the most common 
and widely used synthesis for AuNPs.  This synthesis allows for control over the NP size 
through controlling the concentration of the reactants, and controlling the temperature the 
reaction is allowed to reflux102.  Recently, there has been interest in the use of other 
capping agents for AuNPs that also allows for a simple one pot synthesis.  Some of these 
capping agents are polymers such as PNIPAM55, PAMAM dendrimers36 (ref), and poly(4-
vinylpyridine) (P4VP)56.  P4VP is useful as a capping agent that allows for a one pot 
synthesis because it is an ionophore56.  This allows the Au3+ ions to bind to the polymer 
before being reduced to form AuNPs that can be used to form layers of AuNPs within a 
polymer network56.  The hydrogen bonding interactions used for building up layers allows 
us to extend the application of the P4VP encapsulated AuNPs (P4VP/AuNPs) to other 
processes using the polymers inherent properties.  Knowledge of the polymer as an 
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ionophore and polymer subunits that do not interact with the AuNPs, we can use these 
P4VP/AuNPs to capture metal ions from solution and then be used in a similar manner to 
IMAC resin beads.   
In this study, the application of metal ion coordinated P4VP/AuNPs 
(MC/P4VP/AuNPs) to capture phosphorylated peptides and proteins, is evaluated as a tool 
for phospho-proteomic studies.  The synthesis of P4VP/AuNPs is a simple one pot 
synthesis that proves stable and size controlled AuNPs, affording a platform that is simple 
to tailor toward a specific problem.  This method is advantageous to previously described 
nanoparticle based phospho-peptide/protein pull down experiments27,40,95,103,104 because 
there is no need for further modification of the P4VP/AuNPs prior to metal ion loading on 
the surface using the polymers chemical characteristics.  Once the metal ions have been 
coordinated to the surface of the P4VP/AuNPs creating at MC/P4VP/AuNP complex, the 
loading of phospho-peptides/proteins is simple and allows for multiple experiments to be 
conducted in parallel.  Since MC/P4VP/AuNPs is a solution based method for the selective 
capture of phospho-peptides/proteins, there is no need for the elution steps that are 
typically required when using column based separation techniques37,105, making this 
MC/P4VP/AuNP platform for phospho-proteomics useful in both bottom-up and top-
down approaches.  The method demonstrates a bottom up approach proved useful in 
capturing phospho-peptides in standard tryptic digest solutions for both α and β casein.  
The MC/P4VP/AuNPs are also demonstrated capturing a whole phospho-protein (α 
casein) wherein the protein is this subjected to standard tryptic digest verifying the ability 




Hydrogen tetrachloroaurate (III) (HAuCl4), poly(4-vinylpyridine) (P4VP), 
trifluoroacetic acid (TFA), methanol (MeOH), hydrogen peroxide (H2O2), formic acid 
(FA), phosphoric acid (H3PO4), α-casein, ammonium bicarbonate (NH4HCO3), 2,5-
dihydroxybenzoic acid (DHB), zinc(II) chloride (ZnCl2), and iron(III) chloride (FeCl3) 
were purchased from Sigma Aldrich (St. Louis, MO).  Sodium borohydride (NaBH4) was 
purchased from EMD Chemicals Inc. (Darmstadt, Germany).  Carbon coated copper 400 
mesh grids were purchased from Ted Pella Inc. (Redding, CA). The peptides angiotensin 
I (DRVYIHPFHL), human ACTH clip 18-39 (RPVKVYPNGAEDESAEAFPLEF), 
bradykinin (RPPGFSPFR), bradykinin 2-9 (PPGFSPFR), and substance P 
(RPKPQQFFGLM-NH2) were purchased from American Peptide Company Inc. 
(Sunnyvale, CA).  Phosphopeptides pp60 (v-SRC) autophosphorylation site 
(RRLIEDNEpYTARG), and Aquaporin-2 (254-267) (RQpSVELHSPQSLPR) were 
purchased from AnaSpec Inc. (Fremont, CA).  Molecular weight cutoff filters (MWCO) 
100 kDa and 10 kDa as well as Milli-Q water were obtained from Millipore Corp. 
(Bedford, MA).  All reagents and peptides were used as received without further 
purification. 
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Preparation of Metal Ion Coordinated/P4VP/AuNP 
Gold nanoparticles (AuNPs) were synthesized using the method previously 
published by Hao et al.61.  Following synthesis and ripening, the P4VP encapsulated 
AuNPs were lyophilized to dryness to remove the solvent.  The remaining solid pellets 
were washed twice using 500 µL of 18 MΩ water and resuspended in 0.1% TFA, followed 
by sonication until the pellet was resuspended in solution.  The resulting solution was 
further purified using MWCO filters of 100 kDa, and the solution volume was reduced to 
one tenth the initial volume in 0.1% TFA following purification.   
Coordination of metal ions to the surface of the P4VP encapsulated AuNPs was 
accomplished by first diluting the purified AuNP solution to its initial volume in 0.1% 
TFA.  The AuNP solution was then mixed 1:1 with either 200 mM FeCl3 or 200 mM 
ZnCl2, and the mixture is incubated for 30 minutes.  Clean up of the metal ion coordinated 
P4VP/AuNPs (MC/P4VP/AuNP) was carried out by centrifugation three times using 18 
MΩ and 10 kDa MWCO filters.  The resulting solution of MC/P4VP/AuNPs was then 
used for phosphopeptide capture. 
Standard Phosphopeptide Capture and Controls 
The method of oxoacid modified peptide capture using MC/P4VP/AuNPs involves 
several steps.  First, a 10 µL solution phosphopeptide was mixed with 50 µL of 
MC/P4VP/AuNPs.  The solutions of phosphopeptides used for the capture experiments 
were 100 µM pp60 (v-src) autophosphorylation site and a mixture of phosphopeptides and 
nonphosphopeptides (bradykinin, bradykinin 2-9, angiotensin I, substance P, human 
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ACTH clip (18-39), aquaporin-2 (254-267), and pp60 (v-src) autophosphorylation site) 
each of which was present at a concentration of 100 µM.  After 30 minutes of incubation, 
the mixture of peptides and AuNPs are centrifuged using 10 kDa MWCO filter after this 
washing was carried out with 18 MΩ water.  The 25 µL of remaining solution was used 
spotting for MALDI-MS.  Capture of phospho-peptides from α-casein digest was carried 
out as described above following α casein digest using trypsin.  
The control experiment wherein aquaporin-2 (254-267) is dephosphorylated was 
carried out in a similar manner to the above described procedure for regular phospho-
peptide capture experiments.  The dephosphorylation step was carried out using standard 
protocol with barium hydroxide (Ba(OH) 2 followed by zip tipping to remove any acid or 
Ba(OH)2 (ref).  The control wherein the strength of the binding was examined was carried 
out using a 1:1 mixture of pp60 (v-src) autophosphorylation site and human ACTH clip 
18-39 at 100 µM.  The capture was carried out similarly to the process described above.
However, following the wash step 2 µL of the remaining AuNP solution was mixed with 
DHB 1:1 and spotted for MALDI-MS analysis.  This step was carried out two more times 
equaling three washing steps.   
Whole Phosphoprotein Capture and Digest 
Whole α casein was also captured using the Fe3+/P4VP/AuNPs, this was carried 
out similarly to the phosphopeptide capture wherein 10 µL of protein solution (~10 ng) 
was incubated with 50 µL Fe3+/P4VP/AuNPs for ~30 minutes then the mixture was 
washed using 100kDa MWCO filters and dH2O.  Following this capture the protein 
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Fe3+/P4VP/AuNP complex was submitted to standard trypsin digest protocols106. Briefly, 
the protein was denatured at 90 ºC for 30 minutes then cooled for ~5 minutes; trypsin was 
then added and the digest solution was incubated at 37 ºC overnight to allow for 
completion of the digest.  The following day the digest solution was mixed with matrix 
for MALDI-MS analysis.  The digest of α casein in solution was carried out in using the 
same standard tryptic digest protocols106. 
Preparation for LDI-MS and MALDI-MS 
MALDI-MS of phosphopeptides captured using MC/P4VP/AuNPs was carried out 
by mixing the resulting solution from the capture 1:1 with DHB.  One microliter of the 
resulting mixture was then spotted onto a stainless steel MALDI plate and the spots were 
dried under vacuum.  Samples of standard phosphopeptide capture were analyzed in 
positive mode using a Voyager - DE STR (Applied Biosystems, Framingham, MA), and 
samples of phospho-peptides captured from α casein digest were analyzed in positive 
mode with an ABI 4700 TOF-TOF (AB Sciex, Framingham, MA).  The whole protein 
capture digest solution and the α casein solution digest were mixed 1:1 with DHB matrix, 
then 1 µL of this mixture was spotted onto a sample plate and vacuumed dried the resulting 
spots were analyzed by using an ABI 4800 MALDI TOF/TOF (AB Sciex, Framingham, 
MA).   
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Characterization of P4VP/AuNPs 
Metal binding to P4VP/AuNPs was characterized using several independent 
methods (Scheme 3).  UV-Vis spectroscopy (Agilent 8453, Agilent Technologies, Santa 
Clara, CA) was used to characterize the optical properties of the AuNPs before and after 
metal ions (Fe3+) were bound to the surface (Figure 6).   The spectra representing the 
AuNPs without metal ions bound shows a broad peak centered at ~520 nm, which suggests 
a broad size distribution of around 5 nm.  The signal at ~250 nm corresponds to the 
pyridine subunits of the P4VP polymer.  The UV-Vis spectrum (blue trace) resulting from 
the metal ion capture displays the same two main peaks at ~520 nm and ~250 nm.  The 
peak at ~520 nm corresponding to the SPR of the AuNPs has become narrow; suggesting 
the size of the AuNPs following the Fe3+ capture has become more uniform.   
Scheme 3. A schematic representation of metal ion addition to the P4VP 
encapsulated AuNPs followed by the capture of specific analytes by coordination 
through the metal ions.  
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Figure 6. a. UV-Vis comparison of P4VP encapsulated AuNPs before (red) and after 
(blue) incubation with FeCl3. b. TEM image of P4VP encapsulated AuNPs before 
FeCl3 incubation at 100x magnification. c. TEM image of P4VP encapsulated AuNPs 
after FeCl3 incubation at 200x magnification. The size distribution of the AuNPs 
before FeCl3 incubation is (b) 5.0 + 2.2 nm, and after FeCl3 incubation (c) is 10.6 + 
2.8 nm. Both TEM images have 20 nm scale bars.  
TEM (JEM-1200 EX, JEOL, Peabody, MA) was used to confirm the size of the 
P4VP encapsulated AuNPs size before and after Fe3+ capture (Figure 7b and Figure 7c).  
There is a large size distribution of AuNPs (~5.0 ± 2.2 nm) consistent with the broad peak 
in the UV-Vis spectrum at ~520 nm (Figure 7b).   Addition of Fe3+ (as FeCl3) yields a 
more uniform distribution of AuNP (~10.6 ± 2.8 nm) and the size distribution narrowing  
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corresponds to the narrow peak seen in the UV-Vis spectrum at ~520 nm (Figure 6c). The 
AuNPs’ change in size can be attributed to the AuNPs being etched by the chloride ions 
that dissociate from the FeCl3 solution used to supply the Fe
3+ for the capture67. Etching 
of the AuNPs by the chloride ions could accelerate the process of Ostwald ripening to a 
time scale of ~30 minutes, which is the amount of time the AuNPs are in the FeCl3 solution 
before the capture cleaned up as described previously (see methods).   
The final characterization of the MC/P4VP/AuNPs was carried out using energy 
dispersive x-ray spectroscopy (EDX).  This was achieved by a comparison where a carbon 
coated TEM grid spotted with P4VP/AuNPs and another carbon coated TEM grid was 
spotted with MC/P4VP/AuNPs.  The EDX analysis was performed using a Tecnai G2 F20 
ST FE-TEM (FEI, Hillsboro, OR) equipped with an EDX analyzer.  The EDX spectrum 
of the P4VP/AuNPs before metal ion capture is shown in Figure 7.  In this spectrum, the 
emission lines of Cu and Au are dominant.  However, the spectra obtained from P4VP 
encapsulated AuNPs with Fe3+ bound the Cu and Au emission lines are still present, but 
there are Fe and Cl emission lines also prevalent in the lower energy range < 5 keV (Figure 
8).  These spectral lines confirm that following the incubation of the P4VP encapsulated 
AuNPs with the FeCl3, there is indeed Fe
3+ captured on the surface.  The growth of the 
chloride peak in the EDS spectrum can be explained as a ligand for the iron ions that are 
bound to the polymer on the surface of the AuNPs.   
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Figure 7. EDX spectrum of P4VP encapsulated AuNPs before capture of Fe3+ 
Figure 8. EDX spectrum of P4VP encapsulated AuNPs after capture of Fe3+. 
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Results/Discussion 
MC/ P4VP/AuNP are used for selective capture of oxoacid modified analytes as 
illustrated in Scheme 3.  The P4VP encapsulated AuNPs were treated with metal ions, 
specifically Fe3+ and Zn2+, that have demonstrated a strong affinity for oxoacid modified 
peptides107,108.   These MC/P4VP/AuNPs are then are used to selectively capture 
phosphorylated peptides from both standard mixtures and protein digests, for use in 
bottom-up proteomics in a manner similar to traditional immobilized metal affinity 
chromatography (IMAC).  We also demonstrate the use of MC/P4VP/AuNPs to capture 
whole proteins and digest the proteins while captured on the surface allowing for top-
down proteomics. 
The ability of the MC/P4VP/AuNPs to capture oxoacid modified peptides was 
examined using pp60 (v-src) autophosphorylation site (m/z 1672.2, 
RRLIEDNEpYTARG).  First, the Fe3+/P4VP/AuNPs were used to capture pp60 (v-src) 
autophosphorylation site at a concentration of 100 µM from water as described in the 
experimental section.  When using Fe3+/P4VP/AuNPs to capture oxoacid modified 
peptides, the addition of matrix is required due to the lack of a protonation source within 
the system.  The lack of protonation is an effect of Fe3+ ions binding to the surface of the 
P4VP AuNPs through the pyridyl nitrogens.  The matrix used throughout the entire study 
when analyzing phosphopeptide capture was 2,5-dihydroxybenzoic acid, which has been 
reported to assist in the ionization of phosphorylated peptides109. The mass spectrum 
obtained using methods described in the experimental section shows the protonated signal 
for the phosphorylated peptide (Figure 9). It also contains several peaks that are associated 
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with the pp60 (v-src) autophosphorylation site sample.  The results of the pp60 provided 
proof-of-concept that Fe3+/P4VP/AuNPs efficiently captures phosphopeptides out of 
water.  These data control experiments are necessary to characterize the effects of the 
P4VP polymer and the Fe3+ might have on the capture of the phospho-peptides when using 
Fe3+/P4VP/AuNPs.   
Figure 9. a. MALDI mass spectrum of 100µM pp60 (v-src) autophosphorylation site 
(m/z 1672.2, RRLIEDNEpYTARG) after being captured. The * labeled peaks are 
contaminants from the peptide and/or the matrix used for analysis.  
Several control experiments were performed to determine if the Fe3+ formed a 
metal oxide layer on the surface of the AuNPs or if the P4VP is capturing the Fe3+ ions.  
The control was carried out by incubating the FeCl3 with citrate capped AuNPs, and the 
phosphopeptide capture experiment using pp60 (v-src) autophosphorylation site in water 
was performed.  The resulting solution was analyzed with by MALDI-MS (see 
experimental section).  The mass spectrum did not contain any signals for the pp60 
autophosphorylation site, suggesting there were no metal ions present at the surface to 
facilitate the capture of the phosphate group attached to the peptide.  The absence of 
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analyte signal highlights the need for the P4VP on the surface of the AuNPs; this absence 
also suggests there are pyridine groups that are not bound to the surface of the AuNPs that 
can bind the metal ions, specifically in this case, Fe3+ from a solution of FeCl3.   
A second control was performed to determine if the Fe3+ ions are an important 
factor in the capture of the phospho-peptide.  This control experiment was accomplished 
by incubating pp60 (v-src) autophosphorylation site with P4VP/AuNPs without Fe3+ ions 
present in the solution.  The mass spectra from this sample show no evidence for 
phosphopeptide capture, Figure 10.   Therefore, these two control experiments provide 
evidence that the polymer P4VP is important in capturing the Fe3+, yet plays no significant 
role in capturing the phospho-peptide from solution.  The capture of the phosphopeptide 
is facilitated not by the P4VP but by the Fe3+ ions coordinated to the P4VP polymer on 
the AuNP surface.  The Fe3+ ions are coordinated to the P4VP and do not form a metal 
oxide layer on the AuNPs surface.  These findings demonstrate the importance of the 
P4VP being in the Fe3+/P4VP/AuNP system as a surface modification for the AuNPs, in 
preventing the Fe3+ ions to form a core shell structure with the AuNPs, yet allowing for 
Fe3+ ion coordination in a manner that is accessible to phosphate group which is the PTM 
found for this peptide. 
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Figure 10. a. MALDI-MS spectra of a mixture of 1:1 of 100 µM pp60 (v-src) 
autophosphorylation site (m/z 1672.2, RRLIEDNEpYTARG) and human ACTH 
clip 18-39 (m/z 2465.7, RPVKVYPNGAEDESAEAFPLEF). b. MALDI-MS spectra 
of the above mixture following the capture experiement using P4VP/AuNPs without 
metal ions bound.  
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Figure 11. a. MALDI-MS spectra of a mixture of 1:1 of 100 µM pp60 (v-src) 
autophosphorylation site (m/z 1672.2, RRLIEDNEpYTARG) and human ACTH 
clip 18-39 (m/z 2465.7, RPVKVYPNGAEDESAEAFPLEF). b. MALDI-MS spectra 
of the above mixture following the capture experiment using Fe3+/P4VP/AuNPs 
following the first watch step. c. MALDI-MS spectra of the mixture following the 
capture experiment using Fe3+/P4VP/AuNPs following the second wash step. d. 
MALDI-MS spectra of the mixture following the capture experiment using 
Fe3+/P4VP/AuNPs following the third wash step.  
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Finally, as a control, we wanted to determine the robustness of the 
MC/P4VP/AuNP phosphopeptide capturing method to withstand several washing steps.  
This study was accomplished using a mixture 1:1 of pp60 (v-src) autophosphorylation site 
and human ACTH clip 18-39.  The results of this control, Figure 11, demonstrate the 
ability of this method to bind phosphopeptides strongly enough to withstand several 
washing cycles.  Though the peptide signal for the phosphopeptide decreases significantly 
in the third washing step the signal is still present and sufficient for making an accurate 
assignment of the peptide.   Also from this mixture, peptide ACTH 18-39 
(RPVKVYPNGAEDESAEAFPLEF m/z = 2456.7 pI = 4.25) is retained after the 
phosphopeptide capture.  Human ACTH 18-39 is an acidic peptide which led to peptide 
retention throughout the phosphopeptide capture process through hydrogen bonding 
interactions similarly to the original manuscript published by Hao et al61.  The retention 
of acidic peptides is also known to occur in traditional IMAC columns also88,110. 
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The capture experiment used to simulate a complex system, such as a digest, 
involved a mixture of peptides and phosphopeptides.  The mixture contained two phospho-
peptides and five non-phospho-peptides (Table 1).  The mixture of peptides was treated 
in the same manner as the single phosphopeptide sample.  The results before and after 
phosphopeptide capture are shown (Figure 12).  The spectrum before phosphopeptide 
capture demonstrates the phosphopeptides are present in low abundance relative to the 
other five nonphospho-peptides; these results are typically seen in proteomic samples with 
phosphorylated peptides present111 (Figure 12a).  The mass spectrum taken following the 
phosphopeptide capture illustrates this method’s ability to capture phosphopeptides from 
the mixture and increase their relative abundance in the resulting mass spectrum (Figure 
12b).   
49 
Figure 12. MALDI mass spectra of 10µM phosphorylated peptides mixed with non-
phosphorylated peptides labeled (Table 1.). a. before phospho-capture and b. after 
phospho-capture using the Fe3+ ions bound to the P4VP encapsulated AuNPs.  
Table 1. List of numerical labels of phosphorylated peptides and non-phosphorylated 
peptides with sequence, molecular weight, and pI (MW and pI calculated using 
expasy.org; the phosphopeptide pI was calculated using scansite.mit.edu). * denotes 
the pI of the peptide with phosphorylation. 
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The sequence of the phosphopeptides used in this mixture also contains several 
acidic amino acids including: pp60 (v-src) autophosphorylation site 
(RRLIEDNEpYTARG) and Aquaporin-2 (254-267) (RQpSVELHSPQSLPR).  In the 
original P4VP encapsulated AuNP manuscript, the pyridine subunits not bound to the 
surface of the AuNP were used to build up layers of AuNPs on polymers with acidic 
subunits through hydrogen bonding61. Therefore, another control experiment is necessary 
to determine whether the phosphate group or the acidic amino acid side chains are more 
important during the phospho-peptide capture experiment.  For example, Aquaporin-2 was 
dephosphorylated (see experimental section) to produce a dehydroalanine form of the 
peptide (RQdhaVELHSPQSLPR).  From this protocol, a mixture of both phospho- and 
dephosphopeptide results is seen in the MALDI-MS (Figure 13a).  The dephosphorylated 
peptide is the most abundant ion seen in the mass spectrum and the phosphopeptide is 
~15% of the relative abundance of the dephospho-peptide.  However, when the 
phosphopeptide capture is performed on the mixture, the phosphopeptide becomes the 
most abundant ion observed in the mass spectrum (Figure 13b).  This experiment 
demonstrates the importance of the phosphate group compared to the acidic properties of 
the peptide when employing P4VP encapsulated AuNPs with Fe3+ bound to capture 
phospho-peptides. 
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Figure 13. a. MALDI mass spectrum of 100 µM Aquaporin-2 (254-267) (m/z 1713.8, 
RQpSVELHSPQSLPR-OH) following dephosphorylation. B. MALDI mass 
spectrum of 100 µM Aquaporin-2 (254-267) (m/z 1713.8, RQpSVELHSPQSLPR-
OH) following dephosphorylation and phosphor-capture using Fe3+ ion bound to 
P4VP encapsulated AuNPs.  
The general utility of Fe3+/P4VP/AuNPs for application as a bottom-up 
phosphoproteomic tool was evaluated using a tryptic digest of the phosphoprotein, α and 
β casein.  α casein digest was analyzed before and after the phospho-peptide capture was 
performed using MALDI-MS with DHB, (Figure 14a and Figure 14b).  The mass 
spectrum contains two peaks (labeled with asterisk) at m/z 1951.95 
(YKVPQLEIVPNpSAEER) and m/z 1660.79 (VPQLEIVPNpSAEER), that correspond 
to phosphorylated peptides from the α-casein digest. These two peptides are similar 
peptides; the m/z 1951.95 peptide is the result of a missed tryptic cleavage at the lysine in 
position two for the m/z 1951.95 (YKVPQLEIVPNpSAEER), which would result in the 
52 
m/z 1660.79 peptide.  There are dashed lines that run through the phosphorylated peptide 
peaks for all three spectra (Figure 14).  In the mass spectrum of the digest prior to the 
phospho-peptide capture, the dashed lines represent two phospho-peptide peaks, which 
are not visible above the base line of the spectrum (Figure 14a).  The phospho-peptide 
capture performed using Fe3+/P4VP/AuNPs display an increase in relative abundance of 
the phospho-peptides when compared to the nonphospho-peptides (Figure 14b).  In 
addition to iron, multiple other metal ions have been shown to work in traditional IMAC 
columns, including Zn and Ga107,112.  Since P4VP is a polymer that is used to bind metal 
ions, Zn2+ was used for phospho-peptide capture in place of Fe3+ 82.   The results of the 
phosphopeptide capture of α-casein digest using zinc (II) can be seen in Figure 14c. The 
mass spectrum has the two peaks associated with the phospho-peptides m/z 1951.95 and 
m/z 1660.79 (Figure 14c).   
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Figure 14. MALDI Mass spectra of α casein a. Full digest before phosphopeptide 
enrichment. b. Phosphopeptide enrichment using Zn (II) ions bound to P4VP AuNPs, 
and c. phosphopeptide enrichment using Fe (III) ions bound to P4VP AuNPs. * 
indicates phosphopeptides corresponding to m/z 1951.95 
(YKVPQPLEIVPNpSAEER) and m/z 1660.79 (VPQLEIVPNpSAEER).  
Figure 15. MALDI mass spectra of β casein. a. full digest of β casein before 
phosphopeptides enrichment. b. Phosphopeptide enrichment using Zn (II) ions 
bound to P4VP AuNPs. * indicates phosphopeptides corresponding to m/z 2061.97 
(FQpSEEQQQTEDELGDK). c. Phosphopeptide enrichment using Fe (III) ions 
bound to P4VP AuNPs. * indicates phosphopeptides corresponding to m/z 2061.97 
(FQpSEEQQQTEDELGDK) 
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These data demonstrate this method of phospho-peptide capture is not limited to 
just using Fe3+ as the metal ion used for phospho-peptide capture. The data for β casein 
Figure 15, further demonstrates this methods ability to capture phospho peptides from a 
phospho protein digest using Fe3+ and Zn2+ through the retention of  m/z 2061.97 
(FQpSEEQQQTEDELGDK) following capture.  The data also demonstrates that using 
P4VP encapsulated AuNPs with metal ions bound at the surface have the ability to work 
in proteomic environments that are traditionally encountered in today’s research 
laboratories.   
The use of the Fe3+/P4VP/AuNPs as a top-down phosphoproteomic tool was 
evaluated by submitting a whole phosphoprotein (α casein) to capture and digest on the 
surface of the AuNP complex with no need for elution or special handling steps.  The 
capture was carried out similarly to the capture of phosphopeptides described above, 
where 10 µL of protein was mixed with 50 µL of Fe3+/P4VP/AuNP.  The protein at 10 µg 
was captured and digested off the surface with no elution of the protein, resulting in the 
spectra Figure 16a.   
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Figure 16. Top, MALDI mass spectra of α casein (~10 ng) digested using trypsin. 
Bottom, MALDI mass spectra of α casein after capture using Fe3+/P4VP/AuNPs and 
digested with trypsin. All peptides are labeled using their corresponding residue 
numbers. * indicated peptides not associated with α casein digest fragments. p 
indicated peptides that correspond to phosphorylated peptides.  
Seen in this spectrum are peaks that correspond to 9 peptides from the digest of the protein.  
Of these peptides, there is one peptide present that is a known phosphopeptide at m/z 
1951.95 (119-134, YKVPQLEIVPNpSAEER).  This being the only phosphopeptide 
present in the spectrum is not cause for concern, as the non-phosphopeptides were not 
removed from the sample prior to analysis, to demonstrate the ability of the 
Fe+/P4VP/AuNPs to capture whole proteins and allow for on particle digestion of the 
protein.  This data provides evidence for the ability to digest the protein still on the 
particles, also when comparing the on particle digest to the protein digested from solution 
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(Figure 16b)  there are significantly more peptides present that correspond to the sequence 
of α casein (Table 2). 
Conclusion 
The capture of phosphorylated peptides using poly (4-vinylpyridine) (P4VP) 
encapsulated AuNPs with metal ions bound to the surface is reported using mass 
spectrometry.  The P4VP encapsulated AuNPs were characterized before and after metal 
ion capture in order to determine the physical and/or optical changes the AuNPs might 
undergo.  The method was accomplished and demonstrated using Fe3+ captured on the 
surface of the AuNPs during the incubation step.  It was also determined that after Fe3+ 
was captured on the surface of the AuNPs, the size of the particles became larger and the 
distribution of the sizes became narrower.  Changes in the size distribution is an effect of 
Ostwald ripening that is hastened by halide ion etching of the AuNPs during the FeCl3 
incubation step67.  Following characterization of the physical and optical properties of the 
AuNPs, the AuNPs were used to capture phospho-peptides from mixtures and digest.  We 
first demonstrated the Fe3+/P4VP/AuNPs were able to capture phosphorylated peptides, 
using a single phospho-peptide pp60 (v-src) autophosphorylation site 
(RRLIEDNEpYTARG).  With this peptide, we were able to show the P4VP encapsulated 
AuNPs with metal ions bound are able to capture the phospho-peptide out of water.  
Although the capture is possible using the AuNPs, we had to use a traditional MALDI 
matrix, DHB, because there is no protonation source available on the AuNPs with the 
metal ions and phospho-peptide bound.  Using the AuNPs as the phospho-peptide capture 
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“beads” in solution means there are fewer sample handling steps when compared to 
traditional phosphopeptide capture techniques.   
Table 2. List of peptide fragments with molecular weight, fragment residues, 
modifications, modified fragment molecular weight, and sequence from an α casein 
digest using trypsin (information was determined using expasy.org/peptide_mass/).  
The use of these MC/P4VP/AuNPs to capture phospho-peptides from a protein 
digest was also accomplished using two traditional IMAC metal ions, Fe3+ and Zn2+.  The 
ability to capture phospho-peptides from a protein digest using two different metal ions 
demonstrates the robustness of this method and the applicability of these AuNPs in 
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traditional phosphoproteomic studies in a bottom up approach.  This method also proves 
useful as a tool for whole protein capture and digests which allows for more applications 
in phosphoproteomic studies as a top-down technique.  
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CHAPTER IV  
CYSTEIC ACID MODIFIED PEPTIDE ENRICHMENT USING POLY(4-
VINYLPYRIDINE) COATED GOLD NANOPARTICLES 
Introduction 
Amino acid side chains play important roles in protein function making up active 
sites for enzymatic function and influencing protein structure113.  The side chains of amino 
acid control the function and structure of proteins through various modifications known 
as post translational modifications (PTMs) 64. TMs vary from the addition of alkyl chains 
to reversible phosphorylation 113.  One PTM of interest is the oxidation of cysteine and 
methionine side chain thiols.  The oxidation of these thiols is important for cellular 
processing of reactive oxygen species (ROS) and reactive nitrogen species (RNS) 114,115. 
In the case of cysteine there are three possible oxidation states sulfenic acid (R-SOH), 
sulfinic acid (R-SO2H), and sulfonic acid (R-SO3H) 
116,117.  Sulfenic and sulfinic acid are 
oxidation of the thiol with one and two oxygen’s respectively.  These two oxidation states 
are reversible and are the major pathways for processing of ROS/RNS.  Sulfonic acid 
modified cysteine also known as cysteic acid is the direct product of oxidative stress and 
is irreversible 118,119.  
The study of cysteine oxidation is important and the determination of oxidation 
sites has been studied using several methods.  Reactive cysteines have been profiled using 
isotope-coded affinity tagging (ICAT), attaching the tags to cysteines using thiol reactive 
agents 120. This ICAT method allows for the profiling of reactive cysteines within proteins 
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because the ICAT labeling agent will only interact with thiols that have not been oxidized 
120. While using this method is effective at determining the reactive cysteine sites within
proteins, it lacks in ability to determine the oxidation state of the unlabeled thiols 121.  This 
is a major drawback when trying to determine the oxidation products of cysteine present 
proteins due to the number of possible oxidation states for cysteine. 
Increased interest in the oxidation of cysteine from redox process in cells has lead 
to the development of methods of studying cysteine oxidation that are dependent on the 
oxidation state of the cysteines present in the sample.  Therefore, methods have been 
developed to study cysteine oxidation based on the oxidation states of cysteine have been 
developed.  The first oxidation state of cysteine is sulfenic acid (R-SOH), where the thiol 
has undergone one step of oxidation by ROS or RNS.  This oxidation state has been studied 
by Carroll et al. using dimedone to study cysteine oxidation in cells 122,115.  Dimedone is 
a chemical modifier that selectively targets sulfenic acid over the other oxidation states of 
thiol as well as unoxidized thiol 48,122,115.  The second oxidation state of cysteine is sulfenic 
acid (R-SO2H), this product is formed as the second step in cysteine oxidation and is 
reversible 123.  Sulfinic acid cysteine is a quick reacting intermediate that reacts very 
quickly following two possible pathways i) further oxidation to sulfonic acid cysteine and 
ii) reduction back to the thiol or sulfenic acid cysteine 119. This reaction intermediate is
very unstable and reacts on a time scale that makes studying it very difficult 124.  The final 
oxidation product of cysteine is the most stable, sulfonic acid cysteine (R-SO3H) 
28. 
Sulfonic acid cysteine is the irreversible oxidation of cysteine that can be used in 
determining the oxidative stress levels in cells 119.  There are a few techniques that have 
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been presented previously that work to elucidate sulfonic acid cysteines in peptides and 
proteins.  First, antibodies specific for proteins that have been oxidized have been used for 
selective enrichment of sulfonic acid cysteine in molecular chaperone activity studies 119.  
The next method is more relevant for this study because nanomaterials are the platform 
for enrichment.  Briefly, Chang et al. functionalized nanodiamonds with polyarginine 
which electrostatically interacts with the sulfonic acid allowing for enrichment of the 
modified peptide 28.  This method demonstrates the ability of non-antibody and non-
labeling techniques for the selective enrichment of sulfonic acid cysteine modified 
peptides.  When the nanodiamonds technique was challenged with phospho peptides as a 
possible interference for the electrostatic interaction there was no phospho peptide 
retained, meaning the selectivity of this method is very high even in the presence of other 
similar oxoacid PTMs 28.   
In previous studies nanomaterials have been used for PTM enrichment 52,86,125.  In 
this report we use a one pot synthesis of gold nanoparticles (AuNPs) that are 
functionalized with the polymer poly(4-vinylpyridine) (P4VP) to capture peptides 
containing sulfonic acid cysteines.  Specifically, we use metal ions bound to the surface 
of the AuNPs through the polymer in a manner similar to enrichment used previously for 
phospho-peptides 103.  The metals chosen for this method were Fe3+ and Mn2+ which have 
been shown previously to interact strongly with sulfonic acid in water 116,126. The 
selectivity of this method for sulfonic acid cysteine peptides over phospho-peptides is 




 Hydrogen tetrachloroaurate (III) (HAuCl4), poly(4-vinylpyridine) (P4VP), 
trifluoroacetic acid (TFA), methanol (MeOH), manganese(II) chloride (MnCl2), hydrogen 
peroxide (H2O2), formic acid (FA), phosphoric acid (H3PO4), 2,5-dihydroxybenzoic acid 
(DHB), α-Cyano-4-hydroxycinnamic acid (CHCA), and iron(III) chloride (FeCl3) were 
purchased from Sigma Aldrich (St. Louis, MO).  Sodium borohydride (NaBH4) was 
purchased from EMD Chemicals Inc. (Darmstadt, Germany).  Hydrogen peroxide (35% 
wt/wt) and formic acid (99% wt/wt) were purchased from Acros Organics (Morris Plains, 
NJ, USA).  Carbon coated copper 400 mesh grids were purchased from Ted Pella Inc. 
(Redding, CA). The peptides human ACTH clip 18-39 
(RPVKVYPNGAEDESAEAFPLEF) and flag (DYKDDDDK) were purchased from 
American Peptide Company Inc. (Sunnyvale, CA).  The peptides LVINVCLSQG, 
CLVINLSQR, Aquaporin-2 (254-267) (RQpSVELHSPQSLPR), and pp60 (v-src) 
autophosphorylation site (RRLIEDNEpYTARG) were purchased from AnaSpec Inc. 
(Fremont, CA).  Molecular weight cutoff filters (MWCO) 100 kDa and 10 kDa as well as 
Milli-Q water were obtained from Millipore Corp. (Bedford, MA).  All reagents and 
peptides were used as received without further purification. 
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Preparation of Metal Ion Coordinated/P4VP/AuNP 
Gold nanoparticles (AuNPs) were synthesized using the method previously 
published by Hao et al.61.  Following synthesis and ripening, the P4VP encapsulated 
AuNPs were lyophilized to dryness to remove the solvent.  The remaining solid pellets 
were washed twice using 500 µL of 18 MΩ H2O and resuspended in 0.1% TFA, followed 
by sonication until the pellet was resuspended in solution.  The resulting solution was 
further purified using MWCO filters of 100 kDa, and the solution volume was reduced to 
one tenth the initial volume in 0.1% TFA following purification. The size of the 
P4VP/AuNPs was characterized using TEM (JEM-1200 EX, JEOL, Peabody, MA). 
Coordination of metal ions to the surface of the P4VP encapsulated AuNPs was 
accomplished by first diluting the purified AuNP solution to its initial volume in 0.1% 
TFA.  The AuNP solution was then mixed 1:1 with either 200 mM FeCl3 or 200 mM 
MnCl2, and the mixture is incubated for 30 minutes.  Clean up of the metal ion coordinated 
P4VP/AuNPs (MC/P4VP/AuNP) was carried out by centrifugation three times using 18 
MΩ H2O and 10 kDa MWCO filters.  The resulting solution of MC/P4VP/AuNPs was 
then used for phosphopeptide capture. 
Solution Phase Performic Oxidation 
Peptides containing cysteines were oxidized using a standard oxidation method 
previously described producing LVINVCoxLSQG and CoxLVINLSQR 127. Following 
oxidation the peptides were diluted to 500 µL using 18 MΩ H2O and vacuumed dry.  
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Following this the peptides were then resuspended to 1 mg/mL and stored frozen until 
need for experiments.   
Sulfonic Acid Cysteine Peptide Capture and Controls 
The method of oxoacid modified peptide capture using MC/P4VP/AuNPs involves 
several steps.  First, a 10 µL solution sulfonic acid cysteine peptide (cysteic acid) was 
mixed with 50 µL of MC/P4VP/AuNPs.  The solutions of cysteic acid used for the capture 
experiments were 100 µM LVINVCoxLSQG and CoxLVINLSQR.  A mixture of cysteic 
acid peptide and regular peptides were comprised of either LVINVCoxLSQG mixed 1:1 
with human ACTH clip 18-39 or CoxLVINLSQR mixed 1:1 with flag, all peptides in 
these mixtures were at concentrations of 100 µM.  After 30 minutes of incubation, the 
mixture of peptides and AuNPs are centrifuged using 10 kDa MWCO filter after this 
washing was carried out with 18 MΩ water.  The 25 µL of remaining solution was used 
spotting for MALDI-MS.  A mixture of LVINVCoxLSQG, CoxLVINLSQR, Aquaporin 
2, and pp60 (v-src) autophosphorylation site at a ratio of 1:1 and a concentration of 100 
µM was also made for used with the enrichment method to determine selectivity.  10 µL 
of this mixture was mixed with 50 µL of Mn2+/P4VP/AuNPs the solution was allowed to 
incubate for ~30 minutes before being washed using MWCO filters.  After the washing of 
the mixture the solution was spotted for MALDI-MS analysis. 
Controls were performed using LVINVCLSQG.  The peptide at 100 µM was 
mixed with P4VP/AuNPs and Mn2+/P4VP/AuNPs and subjected to the enrichment method 
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using 10 kDa MWCO filter after this washing was carried out with 18 MΩ water.   The 
resulting solutions were removed and spotted for MALDI-MS analysis. 
Preparation for LDI-MS and MALDI-MS 
MALDI-MS of cysteic acid peptides captured using MC/P4VP/AuNPs was carried 
out by mixing the resulting solution from the capture 1:1 with CHCA.  One microliter of 
the resulting mixture was then spotted onto a stainless steel MALDI plate and the spots 
were dried under vacuum.  Samples of standard cysteic acid peptide capture solutions were 
analyzed in the positive and negative mode using a Voyager - DE STR (Applied 
Biosystems, Framingham, MA).  
Results and Discussion 
Methods employing nanomaterials for enrichment of PTM has become an 
emerging field in proteomic research.  The use of metal ion coordinated P4VP 
encapsulated AuNPs (MC/P4VP/AuNPs) for enrichment sulfonic acid modified cysteines 
(cysteic acid) is described in this report (Scheme 4).  The use of different metal ions is 
demonstrates this methods ability to be applied for selective enrichment of similar PTMs.  
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Scheme 4. A schematic representation of metal ion addition to the P4VP 
encapsulated AuNPs followed by the capture of specific analytes by coordination 
through the metal ions.  
The synthesis of the P4VP/AuNPs is carried out using a method that leads to 
nanoparticles ideal for use in solution based enrichment techniques due to their stability 
and size (Figure 17) allowing simple clean up of samples following enrichment.  
Therefore, following the synthesis and metal ion coordination these MC/P4VP/AuNPs 
were applied to a specific PTM, oxidized cysteines in the form of cysteic acid.  The ability 
for oxoacid PTM to coordinate with metal ions has been described previously in methods 
such as IMAC 110 and other metal ion based techniques 128,110. To being testing the 
MC/P4VP/AuNPs ability to capture cysteic acid modified peptides two peptides were 
chosen containing one oxidation site apiece LVINVCoxLSQG and CoxLVINVLSQR.  
These peptides are very similar in sequence the main difference is the position of the 
cysteic acid.   
Figure 17. TEM image at 100k magnification of P4VP/AuNPs following synthesis 
and clean up. The scale bar is 20 nm.  
 The results of the enrichment of these to peptides at 100 µM using Fe3+/
P4VP/AuNPs from water can been seen in Figure 18.  The ability of Fe3+ ions to 
interaction with sulfonic acid has been studied previously for applications in heavy metal 
removal from water (refs).  The enrichment of cysteic acid modified peptides using 
Fe3+ ions is similar to the enrichment of phosphorylated peptides using Fe3+ ions due 
to their structural and chemical characteristics being similar.  The similarities in phospho 
and cysteic acid PTM allows for the use of the same metal ions; however, in proteomic 
research the ability to selectively enrich PTMs is necessary.   
67 
68 
Figure 18. a. MALDI mass spectrum of 100 µM LVINVCoxLSQG after being 
captured using Fe3+/P4VP/AuNPs. b. MALDI mass spectrum of 100 µM 
CoxLVINVLSQGR after being captured using Fe3+/P4VP/AuNPs.  
Due to the need for selectivity we changed the metal ions from Fe3+ to Mn2+.  Mn2+ 
was selected because other metal ions demonstrated to interact with R-SO3H (ref) were 
tested for coordination to the P4VP/AuNPs.  The other metal ions tested for coordination 
to the P4VP/AuNPs resulted in the aggregation of the AuNPs presumably because the 
P4VP polymer protecting the surface of the AuNPs was removed.  This removal of the 
polymer from the surface of the AuNPs is due to the binding strength of the metal ions to 
the polymer being greater than the binding strength of the polymer to the surface of the 
AuNPs.  These results led to Mn2+ being chosen as the metal ion used in place of Fe3+ for 
cysteic acid modified peptide enrichment using MC/P4VP/AuNPs.  The first proof-of-
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concept experiment wherein Mn2+/P4VP/AuNPs were used to enrich cysteic acid modified 
peptide was performed using LVINVCoxLSQG at 100 µM where following the 
enrichment three wash steps using 18 MΩ H2O, the results of the experiment are displayed 
in Figure 19.  This result suggests the nature of the enrichment using Mn2+/P4VP/AuNPs 
is based on a strong interaction between the Mn2+ ions and the R-SO3H it is also similar 
to enrichment using Fe3+/P4VP/AuNPs.   Due to the results of this proof of concept 
experiment controls to ensure Mn2+/P4VP/AuNPs enrich cysteic acid modified peptides 
is due to interaction of the Mn2+ were performed.  The controls were tested using the 
unoxidized peptide LVINVCLSQG.  The controls provide further evidence that the 
oxidized cysteine plays an important role in the enrichment because no signal for the 
LVINVCLSQG peptide was detected when using Mn2+/P4VP/AuNPs mixed for 
enrichment. 
Figure 19. MALDI mass spectrum of 100 µM LVINVCoxLSQ after being captured 
using Mn2+/P4VP/AuNPs.  
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To further test the ability of Mn2+/P4VP/AuNPs to enrich cysteic acid modified 
peptides a mixture of LVINVCoxLSQG and human ACTH clip 18-39 in a 1:1 ratio was 
subjected to enrichment using Mn2+/P4VP/AuNPs (see methods section).  The results for 
this experiment are presented in Figure 20.  These results are presented in both positive 
and negative ion mode because LVINVCoxLSQG produces predominantly negative ions 
unless alkali metal adducts are formed and the human ACTH clip 18-39 produces 
predominantly positive ions. This experiment demonstrates the ability of the 
MC/P4VP/AuNPs to enrich cysteic acid modified peptides even in the presence of acidic 
peptides.  Acidic peptide binding to MC/P4VP/AuNPs has been previously described 88 
also the binding of acidic peptides to metal ion affinity enrichment methods (IMAC) is 
also a known result.  The ability of Mn2+/P4VP/AuNPs to enrich cysteic acid modified 
peptides has been demonstrated but the selectivity of the method still needs to be explored. 
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Figure 20. a. A negative mode MALDI mass spectrum using CHCA of a mix 
containing 100 µM LVINVCoxLSQG and 100 µM of human ACTH clip 18-39 after 
being captured using Mn2+/P4VP/AuNPs. b. A positive mode MALDI mass spectrum 
using CHCA of a mix containing 100 µM LVINVCoxLSQG and 100 µM of human 
ACTH clip 18-39 after being captured using Mn2+/P4VP/AuNPs. 
To better characterize the selectivity of the Mn2+/P4VP/AuNPs to enrich cysteic acid 
modified peptides over other similar PTMs such as phosphorylated peptides, experiments 
wherein both types of PTM modified peptides were present were performed.  The four 
peptide mixture described in the material methods section containing two cysteic acid and 
two phosphopeptides was mixed with Mn2+/P4VP/AuNPs.  Following the enrichment 
method (see materials methods) the solution was analyzed using MALDI-MS CHCA 
(Figure 21a, 21b) and DHB (Figure 22).  When analyzing the peptide mixture with 
CHCA before enrichment the ionization of the phosphopeptides is suppressed compared 
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to the ionization of the two cysteic acid peptides, Figure 21a.  The preferential ionization 
of the cysteic acid peptides in the original mixture suggests that following enrichment the 
only peptides observed will be the cysteic acid peptides, this result is seen in Figure 21b.  
To better understand the enrichment selectivity of this method using the mixture of 
phosphopeptides and cysteic acid peptides a MALDI matrix needs to be selected that 
allows for the ionization of both types of peptides in the mixture.   
Figure 21. a. A negative mode MALDI mass spectrum using CHCA of a mix 
containing LVINVCoxLSQG, CoxLVINVLSQGR, Aquporin 2 and pp60 (v-src) 
each at 100 µM. b. A negative mode MALDI mass spectrum using CHCA of a mix 
containing LVINVCoxLSQG, CoxLVINVLSQGR, Aquaporin 2 and pp60 (v-src), 
each at 100 µM following enrichment Mn2+/P4VP/AuNPs.  
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Figure 22. a. A negative mode MALDI mass spectrum using DHB of a mix 
containing LVINCoxLSQG, CoxLVINVLSQGR, Aquaporin 2 and pp60 (v-src) 
each at 100 µM. b. A negative mode MALDI mass spectrum using DHB of a mix 
containing LVINCoxLSQG, CoxLVINVLSQGR, Aquaporin 2 and pp60 (v-src) 
each at 100 µM following enrichment using Mn2+/P4VP/AuNPs. 
For this reason DHB was selected as the matrix of choice because it has been previously 
demonstrated to ionize phosphopeptides efficiently due to it being a relatively cool UV 
ionization matrix, thus allowing for the retention of labile posttranslational side chain 
modifications 129. MALDI-MS analysis of the peptide mixture before enrichment using 
DHB as the matrix can be seen in Figure 22a.  This result suggest that DHB will provide 
more insight into whether or not Mn2+ ions allow for selective enrichment of cysteic acid 
peptides over phospho peptides.  The mass spectrum take from the peptide mixture 
following enrichment using Mn2+/P4VP/AuNPs, Figure 22b, shows all four peptides 
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present in the mixture following enrichment using Mn2+ ions.  The signals for the 
phosphopeptides in the mixture are not very abundant following the enrichment but they 
are still present suggesting the Mn2+ ions could be useful for enrichment of any oxoacid 
posttranslational modification.  The results in Figure 21 and Figure 22 suggest the matrix 
chosen for use with this enrichment method plays an important role because the 
phosphopeptides are not well ionized with CHCA; however, when DHB is used as the 
matrix for the MALDI-MS experiment the phosphopeptides are ionized following 
enrichment using Mn2+/P4VP/AuNPs.  This data provides evidence that the use of metal 
ion coordination to selectively enrich oxoacid PTM (i.e. phosphorylation or cysteic acid) 
actually provides limited selectivity.  However, once the PTMs have been enriched the 
ability to selectively ionize each PTM using different matrices has been demonstrated 
using CHCA for cysteic acid containing peptides and DHB for phosphorylation. 
Conclusion 
We have demonstrated the ability of MC/P4VP/AuNPs as a method for enrichment 
of cysteic acid containing peptides, the metal ions use for this PTM enrichment method 
were Fe3+ and Mn2+.  Fe3+ is a commonly used for enrichment of phosphorylation; 
therefore, Mn2+ was used as the metal ions in the MC/P4VP/AuNP method as a way to 
impart selectivity over other oxoacid PTM such as phosphorylation.  The use Mn2+ ions 
to enrich cysteic acid containing peptides have been demonstrated; however, the 
selectivity of Mn2+ for cysteic acid containing peptides over phosphorylation is not 
evident.  The ability to enrich both oxoacid PTMs then ionize selectively using CHCA 
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and DHB has been demonstrated.  The ability to enrich whole subsets of PTMs using 
enrichment nanoparticles then selectively ionize individual PTM types from the 




With the focus of modern research trending toward biochemical issues, it is 
important to understand how molecules interact with surfaces, such as those of AuNPs 
and their protecting agents; this includes optimizing methods to analyze these 
molecules/systems.  The use of poly(4-vinylpyridine) (P4VP) to synthesize AuNPs yields 
not only a small size distribution of AuNPs but incorporates a proton source into the 
system for use in LDI-MS.  From this study we have demonstrated that the use of organic 
solvents to dissolve the peptides can disrupt the hydrophobic interactions between the 
amino acid side chains and the polymer subunits.  This causes the ionization efficiencies 
to be lowered as a result of the decreased interaction with the AuNPs.  Also involved in 
the lowering of the ionization efficiencies is the low availability of protons in the 
P4VP/AuNPs which could be an effect of the proton affinity of pyridine, which can be 
overcome by the solvent being used having excess protons incorporated within them.   
Therefore, we can conclude that solvent effects on peptides interactions are important and 
proton availability is also very important to consider when using P4VP/AuNPs for LDI-
MS of peptides. 
The capture of phosphorylated peptides using poly (4-vinylpyridine) (P4VP) 
encapsulated AuNPs with metal ions bound to the surface is reported using mass 
spectrometry was also studied in this research.  We first demonstrated that 
Fe3+/P4VP/AuNPs were able to capture phosphorylated peptides by using a single 
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phospho-peptide in water.  Although the capture is possible using the AuNPs, we had to 
use a traditional MALDI matrix, DHB, because there is no protonation source available 
on the AuNPs with the metal ions and phospho-peptide bound.  Using the AuNPs as the 
phospho-peptide capture “beads” in solution means there are fewer sample handling steps 
when compared to traditional phosphopeptide capture techniques.   
The use of these MC/P4VP/AuNPs to capture phospho-peptides from a protein 
digest was also accomplished using two traditional IMAC metal ions, Fe3+ and Zn2+.  
The ability to capture phospho-peptides from a protein digest using two different metal 
ions demonstrates the robustness of this method and the applicability of these AuNPs in 
traditional phosphoproteomic studies in a bottom up approach.  This method also proves 
useful as a tool for whole protein capture and digests which allows for more applications 
in phosphoproteomic studies as a top-down technique.   
We have also demonstrated the ability of MC/P4VP/AuNPs as a method for 
enrichment of cysteic acid containing peptides.  Mn2+ was used as the metal ions in the 
MC/P4VP/AuNP method as a way to impart selectivity over other oxoacid PTM such as 
phosphorylation.  The use Mn2+ ions to enrich cysteic acid containing peptides have 
been demonstrated; however, the selectivity of Mn2+ for cysteic acid containing peptides 
over phosphorylation is not evident.  The ability to enrich both oxoacid PTMs then 
ionize selectively using CHCA and DHB is demonstrated.  The ability to enrich whole 
subsets of PTMs using enrichment nanoparticles then selectively ionize individual PTM 
types from the nanoparticles opens the potential for a new type of enrichment methods. 
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